NSPR logo

InspireMD, Inc. Stock Price

NasdaqCM:NSPR Community·US$65.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

NSPR Share Price Performance

US$1.35
-1.25 (-48.08%)
US$1.35
-1.25 (-48.08%)
Price US$1.35

NSPR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

InspireMD, Inc. Key Details

US$9.0m

Revenue

US$6.3m

Cost of Revenue

US$2.6m

Gross Profit

US$51.4m

Other Expenses

-US$48.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-1.01
29.50%
-543.33%
0%
View Full Analysis

About NSPR

Founded
2005
Employees
127
CEO
Marvin Slosman
WebsiteView website
www.inspiremd.com

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Recent NSPR News & Updates

Recent updates

No updates